DelveInsight launched a new report on Pompe Disease Epidemiology Forecast, 2030.
Pompe disease is a rare genetic disease characterized by the abnormal buildup of a sugar molecule called glycogen inside cells. This buildup impairs the working of different organs and tissues, especially the heart, respiratory, and skeletal muscles.
DelveInsight’s ‘Pompe Disease Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Pompe Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Pompe Disease Epidemiology Report:
A study screened almost half a million babies in its first year (2018–2019) and indicated a birth prevalence of 1 in 25,200, which was within the range of previously reported prevalence
The European Pompe Consortium (EPOC) consortium covered at least 1,250 Pompe patients of all ages from 9 European countries and hence deduced the prevalence of Pompe Disease in Europe. The prevalence was estimated to be about 1 in 283,000 (1,250/354 million inhabitants; given that all the patients are still alive) as per the findings
As per Delveinsight’s estimates, in 2020, the prevalent cases of Infantile-onset Pompe Disease and Late-Onset Pompe Disease in Japan were found to be 151 and 926 respectively and are expected to increase by 2030.
Visit for more @ Pompe Disease Epidemiology Insights
Scope of the Pompe Disease Epidemiology report:
The Pompe Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Pompe Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of Pompe Disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Pompe Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Pompe Disease
The report provides the segmentation of the Pompe Disease epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Pompe Disease
3. Pompe Disease Epidemiology Overview at a Glance
4. Pompe Disease: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Pompe Disease
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Pompe Disease-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Pompe Disease Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pompe Disease market. A detailed picture of the Pompe Disease pipeline landscape is provided, which includes the disease overview and Pompe Disease treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States